Literature DB >> 12068421

Osteonecrosis: avoiding total hip arthroplasty.

David S Hungerford1.   

Abstract

Osteonecrosis of the femoral head afflicts approximately 20,000 new patients per year, at an average age of 38. Of the patients seen in our institution, 25% are <25 years old. Without treatment, most of these patients can be expected to need a total hip arthroplasty. Joint-preserving procedures have a significant failure rate, and some have significant morbidity. It is desirable to avoid or delay total hip arthroplasty because most patients with osteonecrosis outlive the current state-of-the-art prostheses. Four issues need to be weighed to arrive at a reasonable algorithm for the preservative treatment of osteonecrosis: i) patient risk factors, ii) morbidity of the proposed procedure, iii) size of the lesion, and iv) stage of the lesion. All of the issues must be considered to make sense out of a complex clinical situation. Copyright 2002, Elsevier Science (USA).

Entities:  

Mesh:

Year:  2002        PMID: 12068421     DOI: 10.1054/arth.2002.33300

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  14 in total

1.  Total hip arthroplasty in steroid-induced osteonecrosis: early functional and radiological outcomes.

Authors:  Wael A Rahman; Donald S Garbuz; Bassam A Masri
Journal:  Can J Surg       Date:  2013-02       Impact factor: 2.089

2.  The natural history of asymptomatic osteonecrosis of the femoral head.

Authors:  Joon Soon Kang; Kyoung Ho Moon; Dae Gyu Kwon; Byung Ki Shin; Min Su Woo
Journal:  Int Orthop       Date:  2013-01-23       Impact factor: 3.075

3.  Psychological distress, personality traits and functional disability in patients with osteonecrosis of the femoral head.

Authors:  Odysseas D Mouzas; Aristidis H Zibis; Konstantinos S Bonotis; Crysanthos D Katsimagklis; George M Hadjigeorgiou; Maria N Papaliaga; Apostolos P Dimitroulias; Konstantinos N Malizos
Journal:  J Clin Med Res       Date:  2014-07-28

4.  Fast sequences MR imaging at the investigation of painful skeletal sites in patients with hip osteonecrosis.

Authors:  Aristidis H Zibis; Sokratis E Varitimidis; Zoe H Dailiana; Apostolos H Karantanas; Dimitrios L Arvanitis; Konstantinos N Malizos
Journal:  Springerplus       Date:  2015-01-06

5.  Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy.

Authors:  Feng-Chen Kao; Yao-Chun Hsu; Chien-Fu Jeff Lin; Ying-Ying Lo; Yuan-Kun Tu
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Differential expression of miR-195-5p in collapse of steroid-induced osteonecrosis of the femoral head.

Authors:  Pengfei Li; Pei Zhai; Zengjie Ye; Peng Deng; Yueguang Fan; Yirong Zeng; Zhihui Pang; Jianchun Zeng; Jie Li; Wenjun Feng
Journal:  Oncotarget       Date:  2017-06-27

Review 7.  Is There a Role of Pharmacological Treatments in the Prevention or Treatment of Osteonecrosis of the Femoral Head?: A Systematic Review.

Authors:  Yun Jong Lee; Quanjun Cui; Kyung-Hoi Koo
Journal:  J Bone Metab       Date:  2019-02-28

Review 8.  Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version).

Authors:  Dewei Zhao; Feng Zhang; Benjie Wang; Baoyi Liu; Lu Li; Shin-Yoon Kim; Stuart B Goodman; Philippe Hernigou; Quanjun Cui; William C Lineaweaver; Jiake Xu; Wolf R Drescher; Ling Qin
Journal:  J Orthop Translat       Date:  2020-01-06       Impact factor: 5.191

9.  Lateral pillar is the key in supporting pre-collapse osteonecrosis of the femoral head: a finite element model analysis of propensity-score matched cohorts.

Authors:  Ji Hoon Bahk; Woo-Lam Jo; Seung-Chan Kim; Soon-Yong Kwon; Young Wook Lim
Journal:  J Orthop Surg Res       Date:  2021-12-20       Impact factor: 2.359

10.  The efficacy of lapine preconditioned or genetically modified IL4 over-expressing bone marrow-derived mesenchymal stromal cells in corticosteroid-associated osteonecrosis of the femoral head in rabbits.

Authors:  Masahiro Maruyama; Seyedsina Moeinzadeh; Roberto Alfonso Guzman; Ning Zhang; Hunter W Storaci; Takeshi Utsunomiya; Elaine Lui; Elijah Ejun Huang; Claire Rhee; Qi Gao; Zhenyu Yao; Michiaki Takagi; Yunzhi Peter Yang; Stuart B Goodman
Journal:  Biomaterials       Date:  2021-06-21       Impact factor: 15.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.